Home » Topics » BioWorld Science

BioWorld Science
RSS

Xcopri wins FDA approval for partial-onset seizures in adults

Nov. 22, 2019

FDA approves Calquence for CLL and SLL

Nov. 22, 2019

New compounds for cancer patented by Hinova Pharmaceuticals

Nov. 22, 2019

Chinese researchers identify BRD4 inhibitors

Nov. 22, 2019

Incyte discloses adenosine A2A and A2B receptor antagonists

Nov. 22, 2019

University of Texas System discloses PTPN11 inhibitors

Nov. 22, 2019

New cannabinoid receptor modulators revealed in recent patent

Nov. 22, 2019

CtBP2 affects multiple pathways in acute kidney injury

Nov. 22, 2019

First-in-human trial with the triple gene construct INXN-4001 for treatment of heart failure

Nov. 22, 2019

Phase II data on AG-10 in ATTR cardiomyopathy support entry into phase III

Nov. 22, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...